Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Merkel

Showing results (291-300 of 434) with videos related to

Pageof 44
Sort By:
Seminars in Arthritis and Rheumatism|September 5, 2024
Advancing composite outcome measures: Insights on weighting components from OMERACT 2023George A Wells, Francis Guillemin, Peter A Merkel, et al.
Annals of the Rheumatic Diseases|August 26, 2010
Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment IndexRavi Suppiah, Oliver Flossman, Chetan Mukhtyar, et al.
JCI Insight|August 26, 2020
Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitisKasia Owczarczyk, Matthew D Cascino, Cecile Holweg, et al.
The Journal of Rheumatology|March 17, 2019
Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018Sibel Z Aydin, Joanna C Robson, Antoine G Sreih, et al.
ACR Open Rheumatology|November 18, 2021
Serum Biomarkers of Disease Activity in Longitudinal Assessment of Patients with ANCA-Associated VasculitisPaul A Monach, Roscoe L Warner, Robert Lew, et al.
Journal of Medical Internet Research|March 2, 2017
Experience With Direct-to-Patient Recruitment for Enrollment Into a Clinical Trial in a Rare Disease: A Web-Based StudyJeffrey Krischer, Peter F Cronholm, Cristina Burroughs, et al.
Arthritis and Rheumatism|March 8, 2005
A serum proteomic approach to gauging the state of remission in Wegener's granulomatosisJohn H Stone, Vinodh N Rajapakse, Gary S Hoffman, et al.
Rheumatology (Oxford, England)|November 8, 2017
Evaluation of damage in giant cell arteritisTanaz A Kermani, Antoine G Sreih, David Cuthbertson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 27, 2018
The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated VasculitisRennie L Rhee, John C Davis, Linna Ding, et al.
Journal of Scleroderma and Related Disorders|May 19, 2017
Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosisDinesh Khanna, Daniel E Furst, Philip J Clements, et al.
Pageof 44

Showing results (291-300 of 434) with videos related to

Sort By:
Pageof 44
Seminars in Arthritis and Rheumatism|September 5, 2024
Advancing composite outcome measures: Insights on weighting components from OMERACT 2023George A Wells, Francis Guillemin, Peter A Merkel, et al.
Annals of the Rheumatic Diseases|August 26, 2010
Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment IndexRavi Suppiah, Oliver Flossman, Chetan Mukhtyar, et al.
JCI Insight|August 26, 2020
Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitisKasia Owczarczyk, Matthew D Cascino, Cecile Holweg, et al.
The Journal of Rheumatology|March 17, 2019
Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018Sibel Z Aydin, Joanna C Robson, Antoine G Sreih, et al.
ACR Open Rheumatology|November 18, 2021
Serum Biomarkers of Disease Activity in Longitudinal Assessment of Patients with ANCA-Associated VasculitisPaul A Monach, Roscoe L Warner, Robert Lew, et al.
Journal of Medical Internet Research|March 2, 2017
Experience With Direct-to-Patient Recruitment for Enrollment Into a Clinical Trial in a Rare Disease: A Web-Based StudyJeffrey Krischer, Peter F Cronholm, Cristina Burroughs, et al.
Arthritis and Rheumatism|March 8, 2005
A serum proteomic approach to gauging the state of remission in Wegener's granulomatosisJohn H Stone, Vinodh N Rajapakse, Gary S Hoffman, et al.
Rheumatology (Oxford, England)|November 8, 2017
Evaluation of damage in giant cell arteritisTanaz A Kermani, Antoine G Sreih, David Cuthbertson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 27, 2018
The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated VasculitisRennie L Rhee, John C Davis, Linna Ding, et al.
Journal of Scleroderma and Related Disorders|May 19, 2017
Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosisDinesh Khanna, Daniel E Furst, Philip J Clements, et al.
Pageof 44